Ischemic stroke is the third cause of death in the developed countries and the main reason
of severe disability. Brain ischemia leads to the production of damage-associated molecular …

Ischemic stroke is a leading cause of death worldwide. A key secondary cell death
mechanism mediating neurological damage following the initial episode of ischemic stroke …

Platelet-rich blood derivatives have been widely used in different fields of medicine and
stem cell-based tissue engineering. They represent natural cocktails of autologous growth …

Neurological disorders, such as stroke, are triggered by a loss of neurons and glial cells.
Ischemic stroke remains a substantial problem for industrialized countries. Over the previous …

Platelet‐based applications such as platelet‐rich plasma (PRP) and platelet releasate have
gained unprecedented attention in regenerative medicine across a variety of tissues as of …

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that typically results
in death within 3–5 years after diagnosis. To date, there is no curative treatment and …

Neurodegenerative disorders of the central nervous system (CNS) and brain traumatic
insults are characterized by complex overlap** pathophysiological alterations …

Ischemic brain injury is associated with a high rate of mortality and disability with no effective
therapeutic strategy. Recently, a growing number of studies are focusing on mesenchymal …

Neuron-specific conventional protein kinase C (cPKC) γ mediates cerebral hypoxic
preconditioning (HPC). In parallel, autophagy plays a prosurvival role in ischemic …

The present study aimed to investigate the effects of early and late administration of platelet-
rich plasma (PRP) on learning-memory and hippocampal synaptic plasticity impairment in …